VITTILABS

Serial Number 97869985
Registration 7415973
700

Registration Progress

Application Filed
Apr 3, 2023
Under Examination
Approved for Publication
Published for Opposition
Registered
Jun 11, 2024

Trademark Image

VITTILABS

Basic Information

Serial Number
97869985
Registration Number
7415973
Filing Date
April 3, 2023
Registration Date
June 11, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 11, 2024
Registration
Registered
Classes
005

Rights Holder

VITTI LABS, LLC

16
Address
Suite 484
4741 Central St.
Kansas City, MO 64112

Ownership History

VITTI LABS, LLC

Original Applicant
16
Kansas City, MO

VITTI LABS, LLC

Original Registrant
16
Kansas City, MO

Legal Representation

Attorney
Anna M. Quinn

USPTO Deadlines

Next Deadline
1673 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-06-11)
Due Date
June 11, 2030
Grace Period Ends
December 11, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

12 events
Date Code Type Description Documents
Jun 11, 2024 NRCS E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 11, 2024 R.SR A REGISTERED-SUPPLEMENTAL REGISTER Loading...
May 7, 2024 CNTA O APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Loading...
Apr 9, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 8, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 8, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 7, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 7, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 7, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 28, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 26, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 6, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
human allograft tissue; animal allograft tissue; pharmaceutical preparations for the treatment of infertility, pulmonary diseases, neurodegenerative diseases, inflammatory diseases, and ocular disorders and diseases
First Use Anywhere: Nov 5, 2019
First Use in Commerce: Nov 5, 2019

Classification

International Classes
005